Sinus Node Dysfunction in Elite Athletes: Clinical Decision-Making

Resting bradycardia is common in highly trained athletes, yet a low pulse is not automatically benign. Endurance training can produce increased vagal tone, larger stroke volume and electrical remodelling that allow the heart to maintain cardiac output with fewer beats. In an elite competitor, a resting rate in the 30s may be a normal adaptation, while the same finding in another athlete may signal clinically important sinus node dysfunction.

The central task is to distinguish physiological athletic bradycardia from disease. Symptoms, the response to exercise, nocturnal rhythm patterns, family history and the persistence of abnormalities after a period of reduced training all contribute to that distinction. A single electrocardiogram rarely provides enough information for a safe decision.

This issue has practical importance in Australia, where athletes may move between club teams, state institutes and the Australian Institute of Sport. A cricketer based in Brisbane, an AFL player in Melbourne and a swimmer training in Sydney can encounter different sports physicians, cardiologists and monitoring systems during the same season. Clear documentation and communication are therefore part of the clinical assessment.

The decision to implant a pacemaker should be based on clinical impact rather than an isolated numerical threshold. A carefully staged process can protect performance, avoid unnecessary device therapy and identify the smaller group at risk of syncope, injury or progressive conduction disease.

Recognising Training-Related Bradycardia

Endurance training increases parasympathetic influence and may remodel the sinus node, atria and atrioventricular conduction system. Resting sinus rates below 50 beats per minute, occasional sinus pauses during sleep and first-degree atrioventricular block can occur in well-conditioned athletes. These findings are more reassuring when the athlete is asymptomatic, has a normal examination and demonstrates an appropriate heart-rate rise during exertion.

Concern increases when bradycardia is accompanied by exertional fatigue, reduced exercise capacity, dizziness, presyncope, syncope or an unexplained decline in performance. A player who can no longer complete repeated high-intensity efforts, or a cyclist whose heart rate fails to rise despite maximal effort, may have chronotropic incompetence rather than simple conditioning.

The timing and setting of symptoms matter. A pause during sleep has a different significance from a pause associated with collapse during training. Similarly, a low rate after a heavy training block may resolve with recovery, whereas persistent daytime bradycardia and impaired rate response require closer investigation.

Building A Reliable Diagnostic Picture

Assessment begins with a detailed history covering training volume, recent illness, weight change, sleep, medications and supplements. Caffeine, stimulants, sedatives and some anti-arrhythmic or psychotropic medicines can alter heart rate. Clinicians should ask about eating-disorder behaviours, low energy availability and symptoms of obstructive sleep apnoea, all of which may influence autonomic function.

A 12-lead ECG should be followed by ambulatory monitoring when symptoms are intermittent. A patch monitor can document pauses, junctional escape rhythms and the relationship between symptoms and rhythm. For an athlete, exercise testing is especially valuable: it assesses chronotropic response, reproduces exertional symptoms and helps separate sinus node disease from a low resting rate caused by vagal conditioning.

Blood tests commonly include thyroid function, electrolytes, full blood count and relevant inflammatory or infectious studies. Echocardiography evaluates structure and function. Cardiac magnetic resonance imaging is appropriate when there are concerning ECG changes, ventricular dysfunction, myocardial inflammation or a family history of cardiomyopathy. The wider arrhythmia differential may include atrial tachyarrhythmias, ventricular ectopy and inherited disease; the literature on ventricular tachycardia ablation illustrates why rhythm diagnosis should precede procedural decisions.

Using Detraining And Follow-Up Carefully

A short period of reduced training can be diagnostically useful in a stable, asymptomatic athlete. The purpose is not to “normalise” every ECG, but to observe whether the sinus rate, pauses or chronotropic response change when the intense autonomic stimulus is removed. The length of this period should reflect the athlete’s symptoms, competition calendar and clinical risk rather than follow a rigid formula.

Repeat ECG, ambulatory monitoring or exercise testing can show whether an abnormality is transient or persistent. A meaningful improvement supports training-related adaptation, although it does not completely exclude intrinsic sinus node disease. Persistent symptoms or an inadequate exercise response should carry more weight than a modest increase in resting pulse.

Follow-up is particularly important for athletes at the end of a competitive career. Autonomic conditioning may lessen after retirement, while underlying conduction disease can become more apparent with age. A historical record of rates, symptoms and test results helps future clinicians avoid interpreting old athletic findings without context.

Deciding When Pacing Is Appropriate

Permanent pacing is generally considered when symptoms are clearly attributable to sinus node dysfunction. This may include recurrent syncope, presyncope that limits participation, symptomatic sinus pauses or chronotropic incompetence causing reproducible exercise intolerance. The clinician should establish a plausible temporal relationship between the rhythm abnormality and the symptom.

An isolated low resting rate, a nocturnal pause or an asymptomatic ECG finding is usually insufficient by itself. Athletes often have long pauses during sleep, and device implantation based solely on a measurement can expose a young person to decades of lead, generator and infection risks without improving performance or safety.

Shared decision-making should address the athlete’s sport, position, collision exposure, travel schedule and career horizon. An elite competitor may prioritise reliable high-rate performance, while another may prefer surveillance if symptoms are mild and risk is low. The discussion should include the possibility of later lead revision, generator replacement, venous obstruction and restrictions during wound healing.

In Australia, access may involve a team physician, a private electrophysiologist, a public hospital service and Medicare-supported testing, with additional device costs shaped by private insurance and hospital arrangements. Early coordination is useful when an athlete is preparing for the AFL season, a national swimming trial or an international tour.

Selecting A Device And Protecting Performance

If pacing is required, the system should preserve atrioventricular synchrony and support the athlete’s expected heart-rate range. A rate-responsive dual-chamber pacemaker is often considered for symptomatic sinus node disease, although programming must be individualised. Rate-response sensors may behave differently during cycling, swimming, rowing or repeated short sprints, so testing under sport-specific conditions is important.

Device implantation can affect contact sports, shoulder movement and training continuity. Lead position, pocket location and fixation should be discussed with the athlete and the implanting specialist. Leadless systems may appear attractive in selected patients, but their suitability depends on pacing needs, age, anatomy, future access and the ability to provide reliable rate response.

Programming should be revisited after rehabilitation and during the return to full training. A device that works well during a treadmill test may perform differently during a long Melbourne cycling session, an AFL match or hot-weather training in Queensland. Remote monitoring can identify arrhythmia episodes, lead problems and battery trends, but it does not replace clinical review.

Athletes should receive written guidance on wound care, electromagnetic exposure, travel documentation and emergency management. Competitive eligibility and anti-doping questions should be handled early through the relevant sporting body. A pacemaker itself is not a performance-enhancing drug, yet associated medicines and supplements still require careful review.

Managing Return To Sport And Long-Term Risk

Return to sport depends on the original symptom, device stability, underlying heart structure and the demands of the discipline. A staged programme can begin with low-impact conditioning, progress to sport-specific intervals and then include unrestricted training if monitoring remains reassuring. Syncope, recurrent palpitations, chest pain or unexpected exercise intolerance should prompt reassessment rather than an automatic increase in workload.

The psychological effect of a device deserves attention. Some athletes fear being viewed as medically fragile, losing selection or becoming dependent on technology. Others may push too hard to prove that treatment has not changed their identity. A sports psychologist, team doctor and electrophysiology service can help align medical safety with realistic performance goals.

Risk-factor management remains relevant after diagnosis. Adequate energy availability, sleep, hydration and recovery support autonomic stability. Clinicians should also screen for harmful coping behaviours when appropriate. Sports medicine wellbeing plans may include financial and behavioural counselling; resources on setting a gambling budget can be relevant when gambling is part of a broader pattern of stress, sleep disruption or risky behaviour, although they do not replace professional assessment.

Long-term review should consider progression to atrial arrhythmias or broader conduction disease. New atrial fibrillation, ventricular dysfunction, unexplained family deaths or exertional syncope should reopen the diagnostic process. An athlete’s status can change as training load, age, illness and competition demands change, so sinus node dysfunction should be managed as a continuing clinical relationship rather than a single test result.

For clinicians caring for elite athletes, the most defensible pathway combines symptom-rhythm correlation, exercise assessment, appropriate imaging and careful observation over time. For athletes, prompt reporting of fainting, exertional decline or unusual fatigue gives the team a better chance to protect both health and career. Journal of Arrhythmia provides open-access research, reviews and electrophysiology guidance to support evidence-based decisions across this complex area of sports cardiology.